ACTRN12609000982213CompletedPhase 2
A double blind randomised controlled, cross over design trial to evaluate the effect of oxytocin nasal spray on eating behaviour, tantrums/rage and weight in people with Prader Willi Syndrome
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- niversity of Sydney
- Enrollment
- 30
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomised controlled trial
- Primary Purpose
- Treatment
- Masking
- Blinded (masking used)
Eligibility Criteria
- Ages
- 12 Years to 30 Years (—)
- Sex
- All
Inclusion Criteria
- •Genetically proven diagnosis of Prader Willi Syndrome
- •Mental age above 10 years
Exclusion Criteria
- •- Persons below 12 years
- •-Persons with a mental age below 10 years
- •- Persons without genetically proven diagnosis of Prader Willi Syndrome
- •- Persons hypersensitive to the preservatives in the nasal spray, viz E216, E218 and chlorobutanol will be excluded.
Investigators
Similar Trials
Completed
Not Applicable
Efficacy of melatonin with ibuprofen chronotherapy after periodontal surgeryCTRI/2023/01/048820Supriya Mishra104
Recruiting
Phase 4
OQ19 for Adult Chronic Inflammatory Lung DiseasesCTRI/2023/01/049001Kartikey Exploration Mining Services Pvt Ltd
Recruiting
Phase 4
Oxygen therapy and myocardial ischaemia during exercise testingMyocardial ischaemiaCardiovascular - Other cardiovascular diseasesACTRN12607000202460Dr Mark Simmonds20
Active, not recruiting
Phase 1
A double blind, prospective, randomised, controlled clinical trial to evaluate the effect of topical phenytoin, on healing, in diabetic foot ulcers. - noneDiabetes Mellitus and associated diabetic foot ulcerationEUCTR2004-004787-74-GBRoyal Group of Hospitals Trust144
Completed
Not Applicable
A prospective , double blind, randomised controlled trial evaluating the effects of mitomycin C on postoperative healing following endoscopic sinus surgery (ESS) to the frontonasal recess.ISRCTN42522811Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)20